Whole Genome Sequencing Identifies Rare Genetic Variants in Familial Pancreatic Cancer Patients

Overview

Journal Ann Hum Genet

Date 2022 Mar 21

PMID 35312039

Authors

Ming Tan

Klaus Brusgaard

Anne-Marie Gerdes

Martin Jakob Larsen

Michael Bau Mortensen

Sonke Detlefsen

Ove B Schaffalitzky de Muckadell

Maiken Thyregod Joergensen

Affiliations

Soon will be listed here.

Citing Articles

Whole genome sequencing identifies rare genetic variants in familial pancreatic cancer patients.

Tan M, Brusgaard K, Gerdes A, Larsen M, Mortensen M, Detlefsen S Ann Hum Genet. 2022; 86(4):195-206.

PMID: 35312039 PMC: 9313800. DOI: 10.1111/ahg.12464.

References

Zhen D, Rabe K, Gallinger S, Syngal S, Schwartz A, Goggins M . BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med. 2014; 17(7):569-77. PMC: 4439391. DOI: 10.1038/gim.2014.153. View

Wu Q, Yin G, Lei J, Tian J, Lan A, Liu S . KLHL5 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Gastric Cancer. Front Mol Biosci. 2020; 7:599110. PMC: 7758449. DOI: 10.3389/fmolb.2020.599110. View

Perkhofer L, Gout J, Roger E, Kude de Almeida F, Baptista Simoes C, Wiesmuller L . DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives. Gut. 2020; 70(3):606-617. PMC: 7873425. DOI: 10.1136/gutjnl-2019-319984. View

Bellido F, Pineda M, Aiza G, Valdes-Mas R, Navarro M, Puente D . POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance. Genet Med. 2015; 18(4):325-32. PMC: 4823640. DOI: 10.1038/gim.2015.75. View

Huang K, Mashl R, Wu Y, Ritter D, Wang J, Oh C . Pathogenic Germline Variants in 10,389 Adult Cancers. Cell. 2018; 173(2):355-370.e14. PMC: 5949147. DOI: 10.1016/j.cell.2018.03.039. View

Roberts N, Norris A, Petersen G, Bondy M, Brand R, Gallinger S . Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. Cancer Discov. 2015; 6(2):166-75. PMC: 4744563. DOI: 10.1158/2159-8290.CD-15-0402. View

McGuigan A, Kelly P, Turkington R, Jones C, Coleman H, McCain R . Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018; 24(43):4846-4861. PMC: 6250924. DOI: 10.3748/wjg.v24.i43.4846. View

Hsu F, Roberts N, Childs E, Porter N, Rabe K, Borgida A . Risk of Pancreatic Cancer Among Individuals With Pathogenic Variants in the ATM Gene. JAMA Oncol. 2021; 7(11):1664-1668. PMC: 8446906. DOI: 10.1001/jamaoncol.2021.3701. View

Momozawa Y, Mizukami K . Unique roles of rare variants in the genetics of complex diseases in humans. J Hum Genet. 2020; 66(1):11-23. PMC: 7728599. DOI: 10.1038/s10038-020-00845-2. View

10.

Hendricks A, Billups S, Pike H, Farooqi I, Zeggini E, Santorico S . ProxECAT: Proxy External Controls Association Test. A new case-control gene region association test using allele frequencies from public controls. PLoS Genet. 2018; 14(10):e1007591. PMC: 6191077. DOI: 10.1371/journal.pgen.1007591. View

11.

McClellan J, King M . Genetic heterogeneity in human disease. Cell. 2010; 141(2):210-7. DOI: 10.1016/j.cell.2010.03.032. View

12.

Kobayashi H, Ohno S, Sasaki Y, Matsuura M . Hereditary breast and ovarian cancer susceptibility genes (review). Oncol Rep. 2013; 30(3):1019-29. DOI: 10.3892/or.2013.2541. View

13.

Tan M, de Muckadell O, Joergensen M . Gene Expression Network Analysis of Precursor Lesions in Familial Pancreatic Cancer. J Pancreat Cancer. 2020; 6(1):73-84. PMC: 7415888. DOI: 10.1089/pancan.2020.0007. View

14.

Earl J, Galindo-Pumarino C, Encinas J, Barreto E, Castillo M, Pachon V . A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants. EBioMedicine. 2020; 53:102675. PMC: 7100610. DOI: 10.1016/j.ebiom.2020.102675. View

15.

Llach J, Carballal S, Moreira L . Familial Pancreatic Cancer: Current Perspectives. Cancer Manag Res. 2020; 12:743-758. PMC: 6999545. DOI: 10.2147/CMAR.S172421. View

16.

Jung H, Yoon S, Lim J, Cho H, Lee H . Dysregulation of Rho GTPases in Human Cancers. Cancers (Basel). 2020; 12(5). PMC: 7281333. DOI: 10.3390/cancers12051179. View

17.

Klein A, Wolpin B, Risch H, Stolzenberg-Solomon R, Mocci E, Zhang M . Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nat Commun. 2018; 9(1):556. PMC: 5805680. DOI: 10.1038/s41467-018-02942-5. View

18.

Nallanthighal S, Heiserman J, Cheon D . The Role of the Extracellular Matrix in Cancer Stemness. Front Cell Dev Biol. 2019; 7:86. PMC: 6624409. DOI: 10.3389/fcell.2019.00086. View

19.

Hansen M, Johansen J, Bjornevoll I, Sylvander A, Steinsbekk K, Saetrom P . A novel POLE mutation associated with cancers of colon, pancreas, ovaries and small intestine. Fam Cancer. 2015; 14(3):437-48. PMC: 4559173. DOI: 10.1007/s10689-015-9803-2. View

20.

Schleifer R, Li S, Nechtman W, Miller E, Bai S, Sharma A . KLHL5 knockdown increases cellular sensitivity to anticancer drugs. Oncotarget. 2019; 9(100):37429-37438. PMC: 6324770. DOI: 10.18632/oncotarget.26462. View